1 active not recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
Follow Daniel Landi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma PEP-CMV - Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood | Phase 1 | Active not recruiting | Daniel Landi | 30 | 2018-06-29 | 2026-06-18 |
| EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma EGFRvIII CAR T cells - Glioblastoma, Gliosarcoma | Phase 1 | Terminated | Daniel Landi | 3 | 2017-02-01 | 2023-02-17 |
Brain Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Medulloblastoma (1)
Automobiles (1) · Immunotherapy, Adoptive (1)
United States (2)
David Ashley, MBBS, FRACP, PhD (1)